Literature DB >> 22778109

Hypophosphataemia-inducing mesenchymal tumour in the foot.

Christa Bauer1, Rolf Brücker, Stefan Bützberger, Christoph Schmid.   

Abstract

Tumour-induced (or oncogenic) osteomalacia is a paraneoplastic syndrome characterised by progressive fatigue, muscle weakness, bone pain, non-healing and recurrent fractures caused by mesenchymal tumours that secrete proteins that inhibit renal phosphate transport and 1α-hydroxylation of 25-OH-vitamin D. The potentially curative treatment of choice is complete surgical excision of the tumour.

Entities:  

Mesh：

Year:  2010        PMID： 22778109      PMCID： PMC3027923          DOI： 10.1136/bcr.06.2009.2034

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  6 in total

1.  [Rickets following bone tumor].

Authors:  A PRADER; R ILLIG; E UEHLINGER; G STALDER
Journal:  Helv Paediatr Acta       Date:  1959-12

2.  Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan.

Authors:  J K Dowman; F H Khattak
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 3.  FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23.

Authors:  Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Bone       Date:  2007-01-04       Impact factor: 4.398

4.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Authors:  Kenneth B Jonsson; Richard Zahradnik; Tobias Larsson; Kenneth E White; Toshitsugu Sugimoto; Yasuo Imanishi; Takehisa Yamamoto; Geeta Hampson; Hiroyuki Koshiyama; Osten Ljunggren; Koichi Oba; In Myung Yang; Akimitsu Miyauchi; Michael J Econs; Jeffrey Lavigne; Harald Jüppner
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394
  6 in total
  2 in total

1.  Severe hypophosphataemia after intravenous iron administration.

Authors:  Gurpreet Anand; Christoph Schmid
Journal:  BMJ Case Rep       Date:  2017-03-13

2.  Phosphaturic mesenchymal tumors among elderly patients: a case report and review of literature.

Authors:  Zaina Adnan; David Nikomarov; Michal Weiler-Sagie; Noga Roguin Maor
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.